SCHEDULE 13G

Coherus Oncology Inc

Common Stock, $0.0001 par value per share · CUSIP: 19249H103

Event date: 2025-09-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Bering Partners II, L.P. ("Bering II")

  Shares: 4,763,062.00 · Class: 4.1%

• Bering Partners II GP, L.L.C. ("Bering II GP")

  Shares: 4,763,062.00 · Class: 4.1%

• Bering Partners III, L.P. ("Bering III")

  Shares: 2,826,446.00 · Class: 2.4%

• Bering Partners III GP, L.L.C. ("Bering III GP")

  Shares: 2,826,446.00 · Class: 2.4%

• Evgeny Zaytsev ("Zaytsev")

  Shares: 7,602,708.00 · Class: 6.5%

• Philip Sawyer ("Sawyer")

  Shares: 7,589,508.00 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.